The Company is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets. The Company was established on April 27, 2000. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on May 22, 2020.
Headquarters
Jeokseon Hyundai Building, 130, Sajik-Ro, Jongno-Gu
Seoul; Seoul;
Contact Details: Purchase the Dream Cis Inc. report to view the information.
Website: http://www.dreamcis.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service